SecBot SecBot
Insider Cluster (3 insiders) ·Filed Apr 30, 2026

NRIX

Nurix Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed6mo ago
Insider cluster: 3 insiders, $0.2M total
Actionable Insight • Neutral

No material insider signal. Monitor for any upcoming clinical trial readouts or partnership announcements that could move the stock; the selling is routine tax-related activity.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$16.81
T+0 close · Apr 30, 2026 · via day close
Latest settled
+40.39%
T+60 · $23.60
Vs SPY
+38.91%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 1 $16.81entry
  2. T+1 · 7mo ago +0.71%α +1.08% · $16.93
  3. T+5 · 6mo ago −1.73%α −4.08% · $16.52
  4. T+20 · 6mo ago +3.45%α −1.81% · $17.39
  5. T+60 · 4mo ago +40.39%α +38.91% · $23.60
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three NRIX insiders (CFO, CLO, CSO) sold a combined $231K in open-market sales, a trivial 0.014% of the company's $1.7B market cap. The selling is routine and does not signal insider concern, especially given the small dollar amounts relative to company size.

Key Financial Metrics

Direction
selling
Total Value
$231.0K
Insiders
3

Key Facts

  • Christine Ring (CLO) sold 8,148 shares at $16.96 for $138K on May 4.
  • Hans van Houte (CFO) sold 2,388 shares at $16.65 for $40K on April 30.
  • Gwenn Hansen (CSO) sold 3,214 shares at $16.65 for $53K on April 30.
  • Total open-market sales: $231K; includes non-cash option exercises at $0.
  • Sales represent 0.014% of NRIX's $1.7B market cap, immaterial.

Financial Impact

Total insider sales of $231K, insignificant relative to market cap.

dilution

Risk Factors

  • Insider selling could increase if stock price rises further, but current levels are routine.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
96% bullish (23 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NRIX-1777932670171

Track record

33 reports on NRIX

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +53.71% at T+20 after the Jun 8, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $15.17 Now $14.73 −2.90% settles Dec 15
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $15.41 Now $14.73 −4.41% settles Dec 15
  4. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $14.84 Now $14.73 −0.74% settles Dec 4
  5. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $14.84 Now $14.73 −0.74% settles Dec 4
  6. Nov 4, 202612d ago 144 Neutral 2/10 Entry $14.84 Now $14.73 −0.74% settles Dec 4
  7. Nov 3, 202613d ago 144 Neutral 2/10 Entry $15.95 Now $14.73 −7.65% settles Dec 3
  8. Nov 3, 202613d ago 8-K Bearish 5/10 Entry $15.95 Now $14.73 +7.65% settles Dec 3
  9. Nov 2, 202614d ago Insider Cluster Neutral 2/10 Entry $25.82 Now $14.73 −42.95% settles Dec 2
  10. Nov 2, 202614d ago 144 Neutral 2/10 Entry $25.82 Now $14.73 −42.95% settles Dec 2
Showing 10 of 33

US Market Status

Market Closed · Opens Wed (10h 53m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 4, 2026